Terminated PHASE3 INTERVENTIONAL 2-arm NCT01773837

Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients

Double-blind, Placebo-controlled, Multicenter Randomized Clinical Trial to Evaluate Short-term Efficacy of Palliative Treatment With Methylphenidate in Asthenia in Advanced Cancer Patients

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Conditions Asthenia

Interventions methylphenidate placebo

Updated 5 times since 2017 Last updated: May 8, 2017 Started: Jan 31, 2012 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow accrual. 100 patients included

Other terminated trials from Clinica Universidad de Navarra, Universidad de Navarra

See all terminations from Clinica Universidad de Navarra, Universidad de Navarra

This PHASE3 trial investigates Asthenia and is currently terminated or withdrawn. Clinica Universidad de Navarra, Universidad de Navarra leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinica Universidad de Navarra, Universidad de Navarra

Data source: Clinica Universidad de Navarra, Universidad de Navarra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pamplona, Spain